Document Type : Case Report
Authors
Shaheed Rajaie Cardiovascular Medical and Research Center, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract
Despite its rarity, pulmonary capillary hemangiomatosis (PCH) presents a significant diagnostic challenge. Due to its similarity to other pulmonary vascular diseases, such as pulmonary veno-occlusive disease, it is characterized by abnormal pulmonary capillary proliferation, which is a rare cause of primary pulmonary hypertension. This case was the first reported instance of PCH in Shahid Rajaee Heart Hospital in Tehran, Iran, in 2023, which was confirmed by genetic testing. It highlighted the importance of considering PCH among the differential diagnoses for pulmonary hypertension, even in adolescent patients. The 13-year-old patient’s main complaints were progressive exertional dyspnea and chest pain. He had no previous medical history and had not taken any pharmaceutical or herbal medications. Critical clinical findings included a heart murmur, an electrocardiogram revealing right ventricular hypertrophy, and echocardiogram evidence of pulmonary hypertension. The main diagnosis was PCH, as shown by CT findings of pulmonary artery dilatation and diffuse nodular ground glass opacities. Genetic tests indicated pathogenic EIF2AK4 mutations and suspicion of PCH. Therapeutic intervention included vasodilator therapy, which exacerbated the patient’s condition. This case emphasized the importance of maintaining a high index of suspicion for rare causes of pulmonary hypertension, such as PCH. The outcome was to prepare the patient for lung transplantation. To differentiate PCH from other pulmonary vascular diseases, a combination of clinical presentation, radiologic studies, genetic analysis, and response to treatment is required to determine appropriate management, particularly lung transplantation.
Keywords
- Maron BA. Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer. J Am Heart Assoc. 2023;12:e029024. doi: 10.1161/JAHA.122.029024. PubMed PMID: 37026538; PubMed Central PMCID: PMCPMC10227272.
- Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53. doi: 10.1183/13993003.01913-2018. PubMed PMID: 30545968; PubMed Central PMCID: PMCPMC6351336.
- Kobayashi H, Otsuki Y, Yamaguchi M, Ko K, Mizuno S, Ujita M, et al. An Autopsy Case of Pulmonary Capillary Hemangiomatosis with an Electron Microscopy Study. Am J Case Rep. 2019;20:1551-7. doi: 10.12659/AJCR.918375. PubMed PMID: 31636247; PubMed Central PMCID: PMCPMC6818641.
- Manjubashini D, Nagarajan K, Rajesh Kumar B. Pulmonary capillary hemangiomatosis: An unusual cause of primary pulmonary hypertension in a child with characteristic computed tomography imaging features. Lung India. 2019;36:157-9. doi: 10.4103/lungindia.lungindia_122_18. PubMed PMID: 30829252; PubMed Central PMCID: PMCPMC6410579.
- Anazawa R, Terada J, Sakao S, Shigeta A, Tanabe N, Tatsumi K. Features of radiological and physiological findings in pulmonary capillary hemangiomatosis: an updated pooled analysis of confirmed diagnostic cases. Pulm Circ. 2019;9:2045894019896696. doi: 10.1177/2045894019896696. PubMed PMID: 31908771; PubMed Central PMCID: PMCPMC6935884.
- Lefebvre B, Kyheng M, Giordano J, Lamblin N, de Groote P, Fertin M, et al. Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients. Eur Radiol. 2022;32:4574-86. doi: 10.1007/s00330-022-08577-x. PubMed PMID: 35286410.
- O’Keefe MC, Post MD. Pulmonary capillary hemangiomatosis: a rare cause of pulmonary hypertension. Arch Pathol Lab Med. 2015;139:274-7. doi: 10.5858/arpa.2013-0500-RS. PubMed PMID: 25611112.
- Park JE, Chang SA, Jang SY, Lee KS, Kim DK, Ki CS. Differential Diagnosis of Pulmonary Veno-Occlusive Disease and/or Pulmonary Capillary Hemangiomatosis after Identification of Two Novel EIF2AK4 Variants by Whole-Exome Sequencing. Mol Syndromol. 2023;14:254-7. doi: 10.1159/000527524. PubMed PMID: 37323202; PubMed Central PMCID: PMCPMC10267509.
- Wagenvoort CA, Beetstra A, Spijker J. Capillary haemangiomatosis of the lungs. Histopathology. 1978;2:401-6. doi: 10.1111/j.1365-2559.1978.tb01734.x. PubMed PMID: 730121.
- Chaisson NF, Dodson MW, Elliott CG. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease. Clin Chest Med. 2016;37:523-34. doi: 10.1016/j.ccm.2016.04.014. PubMed PMID: 27514598.
- Faber CN, Yousem SA, Dauber JH, Griffith BP, Hardesty RL, Paradis IL. Pulmonary capillary hemangiomatosis. A report of three cases and a review of the literature. Am Rev Respir Dis. 1989;140:808-13. doi: 10.1164/ajrccm/140.3.808. PubMed PMID: 2675708.
- Peacock AJ, Naeije R, Rubin LJ. Pulmonary Circulation: Diseases and Their Treatment. 4th ed. Florida: CRC Press; 2016. doi: 10.1201/9781315382753.
- Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, et al. EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Chest. 2014;145:231-6. doi: 10.1378/chest.13-2366. PubMed PMID: 24135949; PubMed Central PMCID: PMCPMC3921094.
- Nayyar D, Muthiah K, Kumarasinghe G, Hettiarachchi R, Celermajer D, Kotlyar E, et al. Imatinib for the treatment of pulmonary arterial hypertension and pulmonary capillary hemangiomatosis. Pulm Circ. 2014;4:342-5. doi: 10.1086/675996. PubMed PMID: 25006453; PubMed Central PMCID: PMCPMC4070788.
)